
novel generic polymerase chain reaction (PCR) with NimbleGen's unique microarray-based platform, makes use of the same RNA (ribonucleic acid) m...rapidly determine whether the strain has developed drug resistance. (...

size. * Identify emerging companies that are likely to compete in the near future with the leading DES manufacturers. Highlights The DES market ...Reportlinker Adds Advances in Drug-Diagnostic Co-Development 4 . Rep...

Chippenham, England-based company said today in a statement. Vectura didn¡¯t identify the drug, which is probably a generic version of Advair, Savvas Neophytou, an analyst at Panmure Gordon & Co. said...

&utm_medium=pr&utm_campaign=Drug_Discovery_and_Development Introduction... but biologically relevant regions of chemical space * Identify in which therapeutic areas the exploration of natural products offers better...

biotechnology, generic drug and medical device companies, announced today that it is collaborating with the Cancer Immunotherapy Trials Network ... cancer immunotherapy and vaccines, in order to help identify trials ...

whether the strain has developed drug resistance. "This new approach takes...regions of the genome, which is important for drug susceptibility. Where virus re-assortment has occurred, it will be able to identify which ...

The drug store would be opened above Bombay Dyeing building on Rajagopala... was being created. Generally, the doctors write brand names in their prescription. To identify equally good and effective generic medicine, ...

Companies from both the brand-name and generic industries need to be careful about what they¡¯re getting into, however. And to identify potential pitfalls, they need only look at the experiences of their rivals...

your drug. - Identify the key players best positioned to capitalize on their products through effective management of their patented products. - Develop effective business strategies related to generic drugs through...

not identify the companies involved, but Glaxo, AstraZeneca, Wyeth, Teva...slow the introduction of generic drugs that could lower government health care costs. That fight is part of a larger struggle. Drug companies ...